QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 限定条件 内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Anlotinib versus sunitinib as first line treatment for metastatic renal cell carcinoma (mRCC): Preliminary results from a randomized phase II clinical trial 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20 作者:  Zhou, Ai-Ping;  Ma, Jianhui;  Bai, Yuxian;  Song, Yan;  Li, Hangzhong 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/04 Anlotinib in metastatic renal cell carcinoma (mRCC) with a previous anti-VEGFR TKI: Preliminary results from a multicenter, phase II trial. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20 作者:  Zhou, Ai-Ping;  Bai, Yuxian;  Song, Van;  Li, Hangzhong;  Xie, Xiaodong 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 Hypertension and myelosuppression as biomarkers of sunitinib efficacy in Chinese patients (pts) with metastatic renal cell carcinoma (mRCC) 会议论文 作者:  Qin, Shukui;  Jin, Jie;  Guo, Jun;  Wang, Jin-Wan;  Zhou, Fang-Jian 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19 Hand-foot syndrome (HFS) and asthenia/fatigue (A/F) as biomarkers of sunitinib efficacy in Chinese patients (pts) with metastatic renal cell carcinoma (mRCC). 会议论文 作者:  Qin, Shukui;  Jin, Jie;  Guo, Jun;  Wang, Jin-Wan;  Zhou, Fang-Jian 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19 Hypertension and myelosuppression as biomarkers of sunitinib efficacy in Chinese patients (pts) with metastatic renal cell carcinoma (mRCC) 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2013-02-20 作者:  Qin, Shukui;  Jin, Jie;  Guo, Jun;  Wang, Jin-Wan;  Zhou, Fang-Jian 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13 Hand-foot syndrome (HFS) and asthenia/fatigue (A/F) as biomarkers of sunitinib efficacy in Chinese patients (pts) with metastatic renal cell carcinoma (mRCC). 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2013-05-20 作者:  Qin, Shukui;  Jin, Jie;  Guo, Jun;  Wang, Jin-Wan;  Zhou, Fang-Jian 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 Axitinib versus sorafenib as second-line therapy in Asian patients with metastatic renal cell carcinoma (mRCC): Results from a registrational study. 会议论文 作者:  Qin, Shukui;  Bi, Feng;  Cheng, Ying;  Guo, Jun;  Ren, Xiu Bao 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 Axitinib versus sorafenib as second-line therapy in Asian patients with metastatic renal cell carcinoma (mRCC): Results from a registrational study. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2012-05-20 作者:  Qin, Shukui;  Bi, Feng;  Cheng, Ying;  Guo, Jun;  Ren, Xiu Bao 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13